US Stock MarketDetailed Quotes
GRTS Gritstone Bio
- 0.071
- +0.017+32.04%
Trading Oct 15 10:07 ET
8.42MMarket Cap-65P/E (TTM)
0.084High0.066Low202.51MVolume0.079Open0.054Pre Close14.99MTurnover175.43%Turnover RatioLossP/E (Static)118.11MShares3.17052wk High0.38P/B8.23MFloat Cap0.04952wk Low--Dividend TTM115.44MShs Float35.200Historical High--Div YieldTTM33.15%Amplitude0.049Historical Low0.074Avg Price1Lot Size
Gritstone Bio Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 13.41%-26.81M | 16.27%-33.57M | -4.92%-121.65M | 35.77%-19.51M | -20.57%-31.09M | -17.56%-30.96M | -19.85%-40.09M | -128.79%-115.95M | -27.73%-30.37M | -73.38%-25.78M |
| Net income from continuing operations | 33.64%-23.4M | -18.84%-40.39M | -15.71%-138.49M | 1.51%-30.82M | -28.26%-38.43M | -19.45%-35.26M | -17.52%-33.98M | -59.41%-119.69M | -5.11%-31.29M | -6.57%-29.97M |
| Operating gains losses | ---- | ---- | --22K | --1K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -15.89%1.6M | -3.17%1.74M | 15.72%7.59M | 7.26%1.92M | 17.18%1.96M | 26.80%1.91M | 13.22%1.8M | 3.36%6.56M | 14.44%1.79M | 5.48%1.68M |
| Other non cash items | -23.31%3.69M | 42.82%3.69M | 62.50%15.48M | 69.98%4.26M | 61.57%3.82M | 107.23%4.81M | 10.85%2.59M | 18.27%9.52M | 8.49%2.51M | 23.01%2.36M |
| Change In working capital | -60.35%-7.32M | 73.61%-3.28M | 30.14%-17.14M | 111.29%648K | 72.04%-808K | -10.91%-4.57M | -5.32%-12.41M | -1,698.17%-24.53M | -503.36%-5.74M | -143.06%-2.89M |
| -Change in prepaid assets | -89.68%894K | 138.56%1.56M | 185.76%5.77M | 102.08%90K | 168.68%1.06M | 431.92%8.67M | -62.63%-4.04M | -66.56%-6.73M | -1,790.83%-4.33M | 33.33%-1.54M |
| -Change in payables and accrued expense | -22.55%-5.41M | 1,104.81%4.39M | -179.14%-3.98M | -88.78%347K | -77.42%525K | -94.28%-4.41M | -123.28%-437K | 265.45%5.03M | 327.35%3.09M | 526.61%2.33M |
| -Change in other current liabilities | 69.02%-3.15M | -50.96%-3.14M | -93.94%-17.29M | 1.18%-2.42M | -15.02%-2.61M | -371.24%-10.17M | -2.36%-2.08M | -12.49%-8.92M | -21.21%-2.45M | -14.65%-2.27M |
| -Change in other working capital | -74.56%345K | -4.00%-6.08M | 88.22%-1.64M | 228.49%2.63M | 115.61%219K | 203.12%1.36M | 36.02%-5.85M | -250.75%-13.91M | -455.29%-2.05M | -112.15%-1.4M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 13.41%-26.81M | 16.27%-33.57M | -4.92%-121.65M | 35.77%-19.51M | -20.57%-31.09M | -17.56%-30.96M | -19.85%-40.09M | -128.79%-115.95M | -27.73%-30.37M | -73.38%-25.78M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -103.60%-885K | -41.89%12.3M | 889.42%102.34M | 182.98%38.3M | 494.50%18.28M | 9.40%24.59M | 177.35%21.17M | 89.06%-12.96M | 1.02%-46.15M | -92.53%3.08M |
| Net PPE purchase and sale | 98.14%-32K | 90.87%-143K | 22.14%-4.57M | 87.12%-191K | 2.76%-1.09M | -18.44%-1.72M | 13.52%-1.57M | -7.49%-5.87M | -11.50%-1.48M | 23.69%-1.12M |
| Net investment purchase and sale | -103.24%-853K | -45.27%12.45M | 1,607.52%106.91M | 186.16%38.49M | 361.40%19.37M | 9.95%26.31M | 140.74%22.74M | 93.72%-7.09M | 0.86%-44.67M | -90.15%4.2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -103.60%-885K | -41.89%12.3M | 889.42%102.34M | 182.98%38.3M | 494.50%18.28M | 9.40%24.59M | 177.35%21.17M | 89.06%-12.96M | 1.02%-46.15M | -92.53%3.08M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,403.74%35.63M | -104.38%-379K | -69.77%25.12M | -75.58%15.72M | -101.37%-264K | 228.06%1.02M | 1,042.97%8.65M | -23.60%83.1M | 95.78%64.37M | -65.92%19.34M |
| Net issuance payments of debt | 17.33%-62K | -100.63%-62K | 4.11%19.68M | 12,317.28%9.9M | -100.31%-60K | -31.58%-75K | 17,810.71%9.92M | 33,853.57%18.9M | -44.64%-81K | --19.1M |
| Net common stock issuance | 5,822.83%38.14M | --0 | -87.50%8.09M | -91.49%5.49M | --0 | --644K | --1.96M | -42.65%64.74M | 87.44%64.49M | -99.56%245K |
| Proceeds from stock option exercised by employees | -58.68%188K | --45K | 9.23%840K | 42.47%369K | -64.44%16K | 23.98%455K | --0 | -82.21%769K | -71.06%259K | -95.92%45K |
| Net other financing activities | -37,557.14%-2.64M | 88.80%-362K | -166.72%-3.49M | 88.20%-36K | -378.26%-220K | ---7K | -236.91%-3.23M | 84.39%-1.31M | 87.12%-305K | -820.00%-46K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,403.74%35.63M | -104.38%-379K | -69.77%25.12M | -75.58%15.72M | -101.37%-264K | 228.06%1.02M | 1,042.97%8.65M | -23.60%83.1M | 95.78%64.37M | -65.92%19.34M |
| Net cash flow | ||||||||||
| Beginning cash position | -10.21%48.93M | 8.97%70.58M | -41.43%64.77M | -53.11%36.07M | -38.80%49.14M | -35.00%54.5M | -41.43%64.77M | -35.35%110.58M | -48.06%76.93M | 23.39%80.3M |
| Current changes in cash | 248.24%7.94M | -110.74%-21.64M | 112.68%5.81M | 383.73%34.5M | -287.95%-13.07M | -50.90%-5.35M | 61.58%-10.27M | 24.24%-45.81M | 67.59%-12.16M | -104.06%-3.37M |
| End cash Position | 15.73%56.87M | -10.21%48.93M | 8.97%70.58M | 8.97%70.58M | -53.11%36.07M | -38.80%49.14M | -35.00%54.5M | -41.43%64.77M | -41.43%64.77M | -48.06%76.93M |
| Free cash flow | 17.87%-26.84M | 19.08%-33.71M | -3.61%-126.22M | 38.16%-19.7M | -19.59%-32.18M | -17.61%-32.68M | -18.13%-41.66M | -116.99%-121.82M | -26.87%-31.86M | -64.64%-26.91M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data